Clinical Trials Directory

Trials / Completed

CompletedNCT02770287

Radiofrequency and Pulsed Electromagnetic Field Treatment of Skin Laxity of the Mon Pubis, Labia and Vaginal Introitus

Clinical Evaluation of the Safety and Efficacy of Using Multi-Polar Radio Frequency and Pulsed Electromagnetic Field Therapy Technologies for the Treatment of the Mon Pubis, Vaginal Introitus and Labia Skin Laxity

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
11 (actual)
Sponsor
Venus Concept · Industry
Sex
Female
Age
25 Years – 65 Years
Healthy volunteers
Accepted

Summary

The study will confirm that the Freeze Diamond polar applicator is safe for treating the Mons pubis and Labia, and will result in improvement in general skin appearance including an improvement in skin irregularities and skin laxity.

Detailed description

This is a single-center, open-label, prospective study. Ten (10) subjects that meet the inclusion criteria will be enrolled from the site's pool of patients. Subjects should be a female at the age of 25-65, and have a suitable treatment area (e.g. skin irregularities and/or unwanted skin laxity in the Mons pubis, Introitus and/or Labia area). Subjects will receive three treatments with the study device, at four week intervals, followed by one month follow-up visits after the last treatment.

Conditions

Interventions

TypeNameDescription
DEVICEVenus Freeze Diamond PolarThe Venus Freeze Diamond Polar is a non-invasive dermatological treatment system that combines Multi Polar Radiofrequency and Pulsed Magnetic Fields. The radiofrequency energy penetrates the skin and results in tissue heating that has known effect on skin laxity, the magnetic field that is simultaneously induces increases fibroblast collagen production through non thermal mechanism and contributes to the clinical effect of skin laxity improvement. Only the Diamond Polar applicator will be used in this study for the treatment of the Mons pubis, vaginal introitus and Labia. Minor modification to the hand-piece for operator and/or patient comfort may occur mid-study, however no change in range of energy modality or amount of energy delivered will occur at any point during the study.

Timeline

Start date
2016-03-26
Primary completion
2017-11-30
Completion
2017-11-30
First posted
2016-05-12
Last updated
2020-04-17
Results posted
2020-01-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02770287. Inclusion in this directory is not an endorsement.